Press release
2023 Bulimia Nervosa Market Size Growing Rapidly with Prestigious Players - GmbH, Philips Healthcare, Abbott, Johnson & Johnson Services, Inc., Stryker , General Electric Company , Covidien ltd, Penumbra, Inc.
Global Bulimia Nervosa Market - Overview
Bulimia nervosa is an eating disorder associated with eating a large amount of food in short time. People suffering from bulimia nervosa is increasing continuously around the globe. As eating disorders are triggered by negative energy balance accompanied by weight loss.
Factors like stress, fat-shaming, nutrition education, pressure to be thin and many more are responsible causing this disorder. Diseases like diabetes and many other cardiovascular diseases are also responsible for increasing the market on bulimia nervosa.
High cost of treatment is the major restraining factor for the growth of the market. Global bulimia nervosa market is expected to grow at a CAGR of 4.5% during forecasted period 2017-2023.
GET FREE SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/1417
According to findings from the WHO in 2014, approximately 422 million people suffered from diabetes. Due to the increasing diabetic population across the globe there is a significant increase in the number of people suffering from cardiovascular diseases. Additionally, increasing geriatric population and increasing healthcare expenditure have fuelled the growth of the market.
According to the World Health Organization (WHO), in 2015, over 17.7 million people died from cardiovascular diseases, representing 31% of all global deaths. According to the Centers for Disease Control and Prevention (2015), over 630,000 Americans died from heart disease each year, which accounted for 1 in every 4 deaths.
According to findings from the WHO, in 2015, 82% of the total deaths were occurred in low- and middle-income countries. Beside this, globally 39% of adults aged 18 years and over were overweight in 2016, and 13% were obese.
Global Bulimia Nervosa Market - Competitive Analysis
Siemens Healthcare GmbH (Germany), Philips Healthcare (U.S), Abbott (U.S), Johnson & Johnson Services, Inc.(U.S), Stryker (U.S), General Electric Company (U.K), Covidien ltd (Ireland), AstraZeneca (U.K) Penumbra, Inc. (U.S) are some of the prominent players at the forefront of competition in the Global Bulimia Nervosa Market and are profiled in MRFR Analysis.
Due to increasing prevalence of bulimia nervosa across the globe many of the companies are in the race to introduce better treatment for bulimia nervosa. Companies are using a trend of strategic alliance and acquisition to gain the market and minimize the competition in the market.
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company headquartered in UK. Recently AstraZeneca has completed its collaboration with National Institute of Mental Health. This collaboration will help to discover the new and better drug treatment for distressing condition.
AstraZeneca has also collaborated with Vanderbilt Center for the Neuroscience Drug Discovery which aims to discover new drug for the treatment of neuropsychiatric disorders.
OBTAIN COMPLETE 80 PAGES PREMIUM RESEARCH REPORT DETAILS ENABLED WITH RESPECTIVE 40+ TABLES AND FIGURES @ https://www.marketresearchfuture.com/reports/bulimia-nervosa-market-1417
Global Bulimia Nervosa Market - Regional Analysis
On regional basis, North America has the leading bulimia nervosa market due to increasing prevalence of this disorder in North America. 6.2 million People are suffering with this bulimia nervosa in North America majority of them are young adults.
Beside this unmet need of medication and technological advances is the other factor for growth of this market in North America.
According to World Population Ageing Report, in 2017, there are an estimated 962 million people aged 60 or over globally, which is 13% of the total global population.
According to the population reference bureau, the number of Americans ageing 65 and older is projected to more than double from 46 million in 2015 to over 98 million by 2060. According to the StastsCan, 2015, over 5.7 million Canadians have aged 65 and older, which was 16.1 % of Canadian population.
According to Statistics Canada projections, this trend will only increase. By 2031, one in four Canadians will be over 65 age. According to the WHO, 2015, Asia's elderly population is projected to reach nearly 923 million by 2050. Growing geriatric is fuelling the number of patients suffering from cardiovascular diseases owing to the high susceptibility of this population pool to developing cardiovascular diseases.
Increasing geriatric population will increase the market for cardiovascular devices since they are more vulnerable towards cardiovascular diseases such as hypertension, stroke, and other diseases. Moreover, increasing healthcare expenditure has provided fuel for the growth of the market.
North America is followed by Europe in bulimia nervosa market. Increasing number of diabetic population, patents suffering from other cardiovascular diseases, technological advances and well developed healthcare sector has led to grow this market in Europe.
Asia Pacific is the fastest growing market due to a huge population base and increasing prevalence of diabetes and other bulimia nervosa causing disease. The Middle East & Africa has the least market for bulimia nervosa.
Major Points form Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Bulimia Nervosa Market, By Type
Chapter 7. Global Bulimia Nervosa Market, By Treatment
Chapter 8 Global Bulimia Nervosa Market, By End User
Chapter 9. Global Bulimia Nervosa Market, By Region
Chapter 10 Company Landscape
Chapter 11 Company Profiles
Chapter 12 MRFR Conclusion
Chapter 13 Appendix
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 2023 Bulimia Nervosa Market Size Growing Rapidly with Prestigious Players - GmbH, Philips Healthcare, Abbott, Johnson & Johnson Services, Inc., Stryker , General Electric Company , Covidien ltd, Penumbra, Inc. here
News-ID: 1376035 • Views: …
More Releases from Market Research Future
9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through …
The 9-decanoic acid methyl ester market is a growing sector driven by the increasing demand for bio-based and sustainable chemical products across various industries. With its unique properties, it finds application in flavors and fragrances, pharmaceuticals, personal care, and as a chemical intermediate. The market is projected to expand significantly in the coming years.
Market Overview and Size
The global 9-decanoic acid methyl ester market was valued at USD 230.0 million in…
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
The washable marker market is a dynamic and growing segment within the broader stationery and art supplies industry. Driven by a blend of consumer demands for safety, convenience, and sustainability, the market is experiencing consistent expansion, particularly within the education and home-use sectors. While faced with some challenges, the industry's future looks promising, propelled by product innovation and evolving consumer trends.
Get Sample @ https://www.marketresearchfuture.com/sample_request/41217
Market Size and Growth
The global washable…
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
The phone car mounts market, a critical sub-segment of the broader automotive accessories industry, is experiencing robust growth driven by a convergence of technological advancements, evolving consumer behavior, and increasingly stringent road safety regulations. As smartphones become indispensable for navigation, communication, and in-car entertainment, the demand for secure and convenient hands-free solutions continues to escalate. The global phone car mounts market was valued at USD 3.93 billion in 2024 and…
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview:
The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical…
More Releases for Bulimia
Bulimia Nervosa Market Overview: Global Size, Share, Analysis, and Forecast till …
"
The Bulimia Nervosa market addresses a critical area within the broader mental health landscape, focused on the diagnosis, treatment, and management of this serious eating disorder. The market's growth is propelled by increasing awareness of mental health issues globally, advancements in therapeutic interventions, and a growing emphasis on early diagnosis and intervention. Technological advancements, particularly in telehealth and digital therapeutics, are expanding access to care, especially in underserved communities. The…
Bulimia Nervosa Treatment Market 2024: Trends, Developments Factors, Competitive …
The Latest study titled Bulimia Nervosa Treatment Market 2024, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2024 to 2031. The comprehensive research delves into the evolving market dynamics, value chain analysis, prominent investment areas, competitive landscape, regional outlook, and key market segments. It also offers a thorough assessment of the global market's drivers and constraints. Additionally, the…
Bulimia Nervosa Market Size to touch USD 1.5 billion by the end of 2032
The global demand for the Bulimia Nervosa market is projected to reach approximately USD 1.5 billion by 2032, up from USD 0.77 billion in 2023, reflecting a robust CAGR of 7.78% over the forecast period from 2024 to 2032. This growth is driven by increasing awareness of eating disorders, advancements in diagnostic and therapeutic approaches, and the rising prevalence of bulimia nervosa. Industry trends indicate a growing emphasis on personalized…
Bulimia Nervosa Treatment Market Analysis Growth Opportunities and Trends by For …
Global Bulimia Nervosa Treatment Market: Overview
Bulimia nervosa refers to a type of eating disorder linked with binge eating following compensatory processes. Patients suffering from bulimia nervosa come with repeated episodes of binge eating that might involve having food in large portions. This eating disorder is also known as binge eating disorder.
GET A BROCHURE OF THE REPORT @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=7106
Affected individuals often eat larger portions than normal individuals under similar circumstances and…
Bulimia Nervosa Treatment Market to Register Unwavering Growth During 2030
Global Bulimia Nervosa Treatment Market: Overview
Bulimia nervosa refers to a type of eating disorder linked with binge eating following compensatory processes. Patients suffering from bulimia nervosa come with repeated episodes of binge eating that might involve having food in large portions. This eating disorder is also known as binge eating disorder. Affected individuals often eat larger portions than normal individuals under similar circumstances and same duration do. These patients often…
Bulimia Nervosa Treatment Market Size, Share, Development by 2024
LP INFORMATION offers a latest published report on Bulimia Nervosa Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Bulimia Nervosa Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019.…
